Literature DB >> 17644243

Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer.

S Bishara1, M Griffin, A Cargill, A Bali, M E Gore, S B Kaye, J H Shepherd, P O Van Trappen.   

Abstract

OBJECTIVE: Inflammatory cells can both suppress and stimulate tumour growth and their influence on clinical outcome in cancer patients has been studied in various cancer types. Here we have investigated their influence on outcome in primary epithelial ovarian cancer. STUDY
DESIGN: Serum white blood cell numbers according to subtype were recorded prior to treatment in 136 patients with primary epithelial ovarian cancer. Their correlation with overall survival and disease-free survival was analysed using both univariate and multivariate analysis adjusting for the known prognostic factors (age, stage and debulking status).
RESULTS: Multivariate analysis demonstrated that a lower lymphocyte fraction of total white blood cells was significantly associated with mortality (p<0.01). On univariate analysis (p=0.0027, HR=1.15), and multivariate analysis of those patients who were optimally debulked (p=0.036, HR=1.17), a higher monocyte count was significantly associated with recurrence. On multivariate analysis amongst those who were suboptimally debulked, a higher eosinophil count was predictive of both recurrence (p=0.0037, HR=1.77) and mortality (p=0.033, HR=1.73).
CONCLUSION: High monocyte counts amongst those who were optimally debulked independently predict adverse outcome in primary epithelial ovarian cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17644243     DOI: 10.1016/j.ejogrb.2007.05.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  32 in total

1.  Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.

Authors:  Naoko Komura; Seiji Mabuchi; Eriko Yokoi; Katsumi Kozasa; Hiromasa Kuroda; Tomoyuki Sasano; Yuri Matsumoto; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2017-09-26       Impact factor: 3.402

2.  Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.

Authors:  Wei-wei Zhang; Ke-jun Liu; Guo-lin Hu; Wei-jiang Liang
Journal:  Tumour Biol       Date:  2015-06-11

3.  Ouabain-induced alterations in ABCB1 of mesenteric lymph nodes and thymocytes of rats and mice.

Authors:  Daniel Boff Lima; Raphael Carmo Valente; Marcia Alves Marques Capella
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

4.  Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score.

Authors:  Seul Ki Kim; Jung Yeon Park; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2014-12-31

5.  Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer.

Authors:  Viren Asher; Joanne Lee; Anni Innamaa; Anish Bali
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

6.  Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.

Authors:  Kristina A Williams; S Intidhar Labidi-Galy; Kathryn L Terry; Allison F Vitonis; William R Welch; Annekathryn Goodman; Daniel W Cramer
Journal:  Gynecol Oncol       Date:  2014-01-23       Impact factor: 5.482

Review 7.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

8.  Utility of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios to distinguish malignant from benign ovarian masses.

Authors:  Murat Bakacak; Salih Serin; Önder Ercan; Bülent Köstü; Mehmet Sühha Bostancı; Zeyneb Bakacak; Hakan Kıran; Gürkan Kıran
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

9.  Plasmonic Nanoparticle-Based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer.

Authors:  Sinyoung Jeong; Germán González; Alexander Ho; Nicholas Nowell; Lauren A Austin; Jawad Hoballah; Fatima Mubarak; Arvinder Kapur; Manish S Patankar; Daniel W Cramer; Petra Krauledat; W Peter Hansen; Conor L Evans
Journal:  ACS Sens       Date:  2020-09-10       Impact factor: 7.711

10.  Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study.

Authors:  Brenda Laky; Monika Janda; Srinivas Kondalsamy-Chennakesavan; Geoffrey Cleghorn; Andreas Obermair
Journal:  BMC Cancer       Date:  2010-05-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.